HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Dihexa |
|---|---|
| CAS number | 1401708-83-5 |
| Molecular formula | C27H44N4O5 |
| Molecular weight | 504.66 g/mol |
| Sequence | Hexanoyl-Tyr-Ile-Ahx-NH2 |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder at -20°C, protected from light and moisture. After reconstitution, keep at 2-8°C and use within the validated short-term window; for longer storage, aliquot and freeze at -20°C to avoid repeated freeze-thaw. Ships with ice packs; confirm lot-specific stability data on the COA. |
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
Dihexa (N-hexanoic-Tyr-Ile-6-aminohexanoic amide; developmental code PNB-0408) is a synthetic, metabolically stabilized analog of angiotensin IV engineered to resist peptidase degradation. In research models it binds hepatocyte growth factor (HGF) and potentiates signaling at the c-Met receptor, and is investigated for neurotrophic and synaptogenic activity.
Documentation
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the Dihexa reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Dihexa is stocked as a lyophilized research-use powder in 5mg vials, with a catalog MOQ of 50 kits (500 vials). Bulk powder, alternative fill weights, and private-label/OEM finishing are available on RFQ.
Every batch is supplied with a Certificate of Analysis reporting HPLC purity and identity confirmation by mass spectrometry. Supplementary documentation such as water content, residual solvent, or third-party assay can be arranged on request.
Standard specification is >=99% by HPLC target, with the exact per-lot value stated on the COA. Tighter or custom specifications can be quoted for OEM programs.
No. Dihexa is supplied strictly as a research-use laboratory material for B2B buyers, research organizations, and formulators. It is not offered as a drug, dietary supplement, or product for consumer use.
Yes. Beyond the 5mg catalog vial we support bulk lyophilized powder, custom fill weights, labeling, and packaging for private-label programs. Lead times and pricing scale with volume and are confirmed on RFQ.
Related compounds